BOLD-100 MoA Research to Be Presented at the AACR Annual Meeting ...Middle East

PR Newswire - News
BOLD-100 MoA Research to Be Presented at the AACR Annual Meeting
PHILADELPHIA, April 9, 2021 /PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, a first-in-class anti-cancer agent, announced that Sandra Van Schaeybroeck, PhD (Queen's University Belfast) will be presenting research supporting BOLD-100 as a...

Hence then, the article about bold 100 moa research to be presented at the aacr annual meeting was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BOLD-100 MoA Research to Be Presented at the AACR Annual Meeting )

Apple Storegoogle play

Last updated :

Also on site :



Latest News